Position in PTGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$13,363,303
-$52,835,801 QoQ
Shares Held
109,017
-82.6% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#64
of 341 holders
Holding Since
Dec 2020
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. PTGX ranks #59 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in PTGX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,363,303 | 109,017 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $66,199,104 | 628,075 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $89,516,948 | 1,024,925 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $72,114,015 | 1,085,564 | Shares | Other | 2025-11-13 | |
| 2024-12-31 | $761,037 | 19,716 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $14,191,785 | 315,373 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $19,825,933 | 572,177 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $28,261,514 | 976,893 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $3,266,837 | 142,470 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $362,739 | 21,747 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $4,543,490 | 164,500 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $31,419,840 | 1,366,080 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $15,868,005 | 1,454,446 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $6,868,140 | 814,726 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $3,670,690 | 464,057 | Shares | Other | 2022-08-15 | |
| 2021-03-31 | $2,245,296 | 86,691 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,354,567 | 116,794 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||